![]() |
CiteULike | ![]() |
Group: C. elegans / WormBase | ![]() |
![]() |
|
![]() |
Register | ![]() |
Log in | ![]() |
A Cell Cycle Regulator in the Germ Lineby: N. R. Ashcroft, A. Golden
|
Reviews
[Write a review of this article]
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
Posting History
AbstractCyclin dependent kinases control cellular events throughout different stages of the cell cycle. One of these kinases, CDC2, regulates the cell's entry into mitosis. CDC2 itself is regulated by a dual specificity phosphatase called CDC25. This phosphatase removes inhibitory phosphates from CDC2, thus driving the cell into M-phase. Whereas other organisms are known to have between one and three cdc25 genes, four cdc25 homologues have been identified in the C. elegans genome (named cdc-25.1 , cdc-25.2 , cdc-25.3 and cdc-25.4 ). We have described the expression pattern of cdc-25.1 using an affinity purified antibody. CDC-25.1 was localized to maturing oocytes, and was observed in the nuclei and cortical membranes of young embryos. CDC-25.1 was also found in the larval germ line precursor cells, Z2 and Z3. Disruption of cdc-25.1 expression using RNAi resulted in the majority of embryos from injected hermaphrodites failing to hatch. These embryos were aneuploid. Further analysis suggested that this aneuploidy was due to aberrant meioses after the oocytes were fertilized. However, the few embryos treated with RNAi that did hatch developed into agametic Glp-like adults. This same sterile phenotype was observed in a molecular null cdc-25.1 mutant ( nr2036 allele generated by Nemapharm, Inc.). Both hermaphrodites and males were sterile. The somatic gonad appeared to develop normally, but the proliferating germ cells died after the L3 larval stage - a time when wild type germ cells enter meiosis. Transgenes containing wild type copies of cdc-25.1 weakly rescued the sterility. Point mutations were introduced into the CDC-25.1 phosphatase domain and these transgenes behaved like dominant negatives. Further analysis of the cdc-25.1 mutant will be presented at the meeting. Research sponsored by the National Cancer Institute, DHHS, under contract with ABL.
BibTeX record
RIS record